|
1
|
Bhoo-Pathy N, Yip CH, Hartman M, et al:
Breast cancer research in Asia: adopt or adapt Western knowledge?
Eur J Cancer. 49:703–709. 2013. View Article : Google Scholar
|
|
2
|
Kim H, Park GS, Lee JE and Kim JH: A
leukotriene B4 receptor-2 is associated with paclitaxel resistance
in MCF-7/DOX breast cancer cells. Br J Cancer. 109:351–359. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ajabnoor GM, Crook T and Coley HM:
Paclitaxel resistance is associated with switch from apoptotic to
autophagic cell death in MCF-7 breast cancer cells. Cell Death Dis.
3:e2602012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carrara L, Guzzo F, Roque DM, et al:
Differential in vitro sensitivity to patupilone versus paclitaxel
in uterine and ovarian carcinosarcoma cell lines is linked to
tubulin-beta-III expression. Gynecol Oncol. 125:231–236. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yin S, Zeng C, Hari M and Cabral F: Random
mutagenesis of beta-tubulin defines a set of dispersed mutations
that confer paclitaxel resistance. Pharm Res. 29:2994–3006. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang J, Zhao J, Zhang W, et al:
Establishment of paclitaxel-resistant cell line and the underlying
mechanism on drug resistance. Int J Gynecol Cancer. 22:1450–1456.
2012.PubMed/NCBI
|
|
7
|
Bhattacharya R and Cabral F: Molecular
basis for class V beta-tubulin effects on microtubule assembly and
paclitaxel resistance. J Biol Chem. 284:13023–13032. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miller AV, Hicks MA, Nakajima W,
Richardson AC, Windle JJ and Harada H: Paclitaxel-induced apoptosis
is BAK-dependent, but BAX and BIM-independent in breast tumor. PLoS
One. 8:e606852013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Youns M, Hoheisel JD and Efferth T:
Traditional Chinese medicines (TCMs) for molecular targeted
therapies of tumours. Curr Drug Discov Technol. 7:37–45. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee H, Lee G, Kim H and Bae H: Paeonol, a
major compound of moutan cortex, attenuates Cisplatin-induced
nephrotoxicity in mice. Evid Based Complement Alternat Med.
2013:3109892013.PubMed/NCBI
|
|
11
|
Huang H, Chang EJ, Lee Y, Kim JS, Kang SS
and Kim HH: A genome-wide microarray analysis reveals
anti-inflammatory target genes of paeonol in macrophages. Inflamm
Res. 57:189–198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee B, Shin YW, Bae EA, et al:
Antiallergic effect of the root of Paeonia lactiflora and its
constituents paeoniflorin and paeonol. Arch Pharm Res. 31:445–450.
2008. View Article : Google Scholar
|
|
13
|
Ishiguro K, Ando T, Maeda O, et al:
Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and
STAT1 transactivation. Toxicol Appl Pharmacol. 217:35–42. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou J, Zhou L, Hou D, Tang J, Sun J and
Bondy SC: Paeonol increases levels of cortical cytochrome oxidase
and vascular actin and improves behavior in a rat model of
Alzheimer’s disease. Brain Res. 1388:141–147. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu SP, Sun GP, Shen YX, Peng WR, Wang H
and Wei W: Synergistic effect of combining paeonol and cisplatin on
apoptotic induction of human hepatoma cell lines. Acta Pharmacol
Sin. 28:869–878. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SA, Lee HJ, Ahn KS, et al: Paeonol
exerts anti-angiogenic and anti-metastatic activities through
downmodulation of Akt activation and inactivation of matrix
metalloproteinases. Biol Pharm Bull. 32:1142–1147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan L, Song B, Sun G, Ma T, Zhong F and
Wei W: Endoplasmic reticulum stress-induced resistance to
Doxorubicin is reversed by paeonol treatment in human
hepatocellular carcinoma cells. PLoS One. 8:e626272013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
von Lindern M, van Baal S, Wiegant J, Raap
A, Hagemeijer A and Grosveld G: Can, a putative oncogene associated
with myeloid leukemogenesis, may be activated by fusion of its 3′
half to different genes: characterization of the set gene. Mol Cell
Biol. 12:3346–3355. 1992.PubMed/NCBI
|
|
19
|
Canela N, Rodriguez-Vilarrupla A, Estanyol
JM, et al: The SET protein regulates G2/M transition by modulating
cyclin B-cyclin-dependent kinase 1 activity. J Biol Chem.
278:1158–1164. 2003. View Article : Google Scholar
|
|
20
|
Zhang P, Compagnone NA, Fiore C, et al:
Developmental gonadal expression of the transcription factor SET
and its target gene, P450c17 (17alpha-hydroxylase/c17,20 lyase).
DNA Cell Biol. 20:613–624. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wagner S, Weber S, Kleinschmidt MA, Nagata
K and Bauer UM: SET-mediated promoter hypoacetylation is a
prerequisite for coactivation of the estrogen-responsive pS2 gene
by PRMT1. J Biol Chem. 281:27242–27250. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Madeira A, Pommet JM, Prochiantz A and
Allinquant B: SET protein (TAF1beta, I2PP2A) is involved in
neuronal apoptosis induced by an amyloid precursor protein
cytoplasmic subdomain. Faseb J. 19:1905–1907. 2005.PubMed/NCBI
|
|
23
|
Almeida LO, Goto RN, Pestana CR, et al:
SET overexpression decreases cell detoxification efficiency: ALDH2
and GSTP1 are downregulated, DDR is impaired and DNA damage
accumulates. FEBS J. 279:4615–4628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boqun X, Xiaonan D, Yugui C, et al:
Expression of SET protein in the ovaries of patients with
polycystic ovary syndrome. Int J Endocrinol. 2013:3679562013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cervoni N, Detich N, Seo SB, Chakravarti D
and Szyf M: The onco-protein Set/TAF-1beta, an inhibitor of histone
acetyltransferase, inhibits active demethylation of DNA,
integrating DNA methylation and transcriptional silencing. J Biol
Chem. 277:25026–25031. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Switzer CH, Cheng RY, Vitek TM,
Christensen DJ, Wink DA and Vitek MP: Targeting SET/I (2) PP2A
oncoprotein functions as a multi-pathway strategy for cancer
therapy. Oncogene. 30:2504–2513. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen S, Dong Q, Hu S, et al: Proteomic
analysis of the proteins that are associated with the resistance to
paclitaxel in human breast cancer cells. Mol Biosyst. 10:294–303.
2014. View Article : Google Scholar
|
|
28
|
Chen LM, Liang YJ, Ruan JW, et al:
Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo
by FG020318. J Pharm Pharmacol. 56:1061–1066. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu XD, Sun H and Liu GT:
5-Bromotetrandrine enhances the sensitivity of doxorubicin-induced
apoptosis in intrinsic resistant human hepatic cancer Bel7402
cells. Cancer Lett. 292:24–31. 2010. View Article : Google Scholar
|
|
30
|
Fazly BB, Iranshahi M, Naderinasab M,
Hajian S, Sabeti Z and Masumi E: Evaluation of the effects of
galbanic acid from Ferula szowitsiana and conferol from F.
badrakema, as modulators of multi-drug resistance in clinical
isolates of Escherichia coli and Staphylococcus aureus. Res Pharm
Sci. 5:21–28. 2010.
|
|
31
|
Cai J, Chen S, Zhang W, et al: Salvianolic
acid A reverses paclitaxel resistance in human breast cancer MCF-7
cells via targeting the expression of transgelin 2 and attenuating
PI3 K/Akt pathway. Phytomedicine. 21:1725–1732. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen SY, Hu SS, Dong Q, et al:
Establishment of paclitaxel-resistant breast cancer cell line and
nude mice models and underlying multidrug resistance mechanisms in
vitro and in vivo. Asian Pac J Cancer Prev. 14:6135–6140. 2013.
View Article : Google Scholar
|
|
33
|
Nakanishi T and Ross DD: Breast cancer
resistance protein (BCRP/ABCG2): its role in multidrug resistance
and regulation of its gene expression. Chin J Cancer. 31:73–99.
2012. View Article : Google Scholar
|
|
34
|
Li Z, Tian T, Hu X, et al: Six1 mediates
resistance to paclitaxel in breast cancer cells. Biochem Biophys
Res Commun. 441:538–543. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Leopoldino AM, Squarize CH, Garcia CB, et
al: SET protein accumulates in HNSCC and contributes to cell
survival: antioxidant defense, Akt phosphorylation and AVOs
acidification. Oral Oncol. 48:1106–1113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rooswinkel RW, van de Kooij B, de Vries E,
et al: Anti-apoptotic potency of Bcl-2 proteins primarily relies on
their stability, not binding selectivity. Blood. 123:2806–2815.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mao Z, Zhou J, Luan J, Sheng W, Shen X and
Dong X: Tamoxifen reduces P-gp-mediated multidrug resistance via
inhibiting the PI3K/Akt signaling pathway in ER-negative human
gastric cancer cells. Biomed Pharmacother. 68:179–183. 2014.
View Article : Google Scholar
|
|
38
|
Kazi AA, Gilani RA, Schech AJ, et al:
Nonhypoxic regulation and role of hypoxia-inducible factor 1 in
aromatase inhibitor resistant breast cancer. Breast Cancer Res.
16:R152014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheng L, Luo S, Jin C, Ma H, Zhou H and
Jia L: FUT family mediates the multidrug resistance of human
hepatocellular carcinoma via the PI3K/Akt signaling pathway. Cell
Death Dis. 4:e9232013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pick A and Wiese M: Tyrosine kinase
inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP
cells via the PI3K/Akt signaling pathway. Chem Med Chem. 7:650–662.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yin J, Wu N, Zeng F, Cheng C, Kang K and
Yang H: Paeonol induces apoptosis in human ovarian cancer cells.
Acta Histochem. 115:835–839. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bao MH, Zhang YW and Zhou HH: Paeonol
suppresses oxidized low-density lipoprotein induced endothelial
cell apoptosis via activation of LOX-1/p38MAPK/NF-kappaB pathway. J
Ethnopharmacol. 146:543–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ponnurangam S, Standing D, Rangarajan P
and Subramaniam D: Tandutinib inhibits the Akt/mTOR signaling
pathway to inhibit colon cancer growth. Mol Cancer Ther.
12:598–609. 2013. View Article : Google Scholar : PubMed/NCBI
|
